Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

8

Revenue 2017

AbbVie

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AbbVie's 2013 sales performance.

AbbVie

AbbVie shares positive results from head-to-head study of Skyrizi in Crohn's disease

AbbVie shares positive results from head-to-head study of Skyrizi in Crohn's disease

AbbVie has shared positive top-line results from a head-to-head study of its interleukin-23 inhibitor Skyrizi (risankizumab) in Crohn's disease. ... All secondary endpoints achieved statistical significance for superiority versus Stelara, AbbVie said,

Novartis sues US government over Medicare drug price negotiation programme

Novartis sues US government over Medicare drug price negotiation programme Johnson &Johnson's Stelara (ustekinumab) and Xarelto (rivaroxaban) were also listed, as well as its AbbVie-partnered Imbruvica (ibrutinib).

US government announces first ten drugs subject to Medicare pricing negotiations

US government announces first ten drugs subject to Medicare pricing negotiations Johnson &Johnson's Stelara (ustekinumab) and Xarelto (rivaroxaban) are also listed, as well as its AbbVie-partnered Imbruvica (ibrutinib).

AstraZeneca’s rare disease unit to acquire Pfizer’s early-stage gene therapies for $1bn

AstraZeneca’s rare disease unit to acquire Pfizer’s early-stage gene therapies for $1bn The company, along with AbbVie, Amgen, Bayer and Merck, will now co-fund the whole-genome sequencing of 250, 000 samples and have access to the resulting data for use in

AbbVie doses first patient in phase 3 study of Rinvoq in hidradenitis suppurativa

AbbVie doses first patient in phase 3 study of Rinvoq in hidradenitis suppurativa AbbVie has announced that the first patient has been dosed in a late-stage study of its selective JAK inhibitor, Rinvoq (upadacitinib), in adults and adolescents with moderate-to-severe hidradenitis ... There is no cure for HS, and there are limited

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

PMHub

Add my company
Medscape Education Global

Medscape delivers dynamic, innovative education to optimize learner engagement and patient outcomes worldwide....

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....